Description
Results
Understanding your test results
- An antibody titre of <25.6 BAU/ml means that no antibodies against the coronavirus have been found in your blood.
- An antibody titre between ≥25.6 to <35.2 BAU/ml indicates a low quantity of antibodies are present in your blood, causing an unclear result.
- An antibody titre ≥35.2 BAU/ml means that your body has produced antibodies against the coronavirus. The higher the value, the higher the number of antibodies.
How results are shared
We understand that blood test results can be confusing. That’s why at Homed-IQ, we make it easy for you to interpret your results and understand what’s going on inside your body.
In your personal online dashboard, you can view your test results and access clear and simple explanations about individual health markers. All test results are verified by our qualified medical team before being sent to you.
The result of your antibody test is shown on a scale from which you can easily see how your results compare to the highest and lowest possible antibody titers.
Scientists are still determining how COVID-19 antibody levels affect immunity and the risk of reinfection. However, it is proven that people with COVID-19 antibodies are less likely to develop another infection than those without these antibodies. The durability of this immunity has yet to be determined. The QuantiVac antibody test allows users to measure their antibody levels at different stages after vaccination, which can be very helpful in getting a better understanding of COVID-19 immunity over time.
How results are shared
We understand that blood test results can be confusing. That’s why at Homed-IQ, we make it easy for you to interpret your results and understand what’s going on inside your body.
In your personal online dashboard, you can view your test results and access clear and simple explanations about individual health markers. All test results are verified by our qualified medical team before being sent to you.
The result of your antibody test is shown on a scale from which you can easily see how your results compare to the highest and lowest possible antibody titers.
Scientists are still determining how COVID-19 antibody levels affect immunity and the risk of reinfection. However, it is proven that people with COVID-19 antibodies are less likely to develop another infection than those without these antibodies. The durability of this immunity has yet to be determined. The QuantiVac antibody test allows users to measure their antibody levels at different stages after vaccination, which can be very helpful in getting a better understanding of COVID-19 immunity over time.
Test Instructions
About the Test
Introduction
When you become infected with COVID-19, your body has a natural defence mechanism, as with all viral infections. In this reaction, your immune system is activated to defend itself against the virus. After an average of 10 to 14 days memory antibodies (IgG) will be produced. While IgA and IgM antibodies disappear from the bloodstream over time, IgG stays in the body longer and ensures that the immune response to the same virus will be much faster and more effective than the first exposure. This means that the immune system can respond immediately and provides protection against the virus.
The strength of the antibody response depends on several factors, including age, disease severity, and certain medications or infections that may suppress the immune system. It can take 2 to 3 weeks for your body to produce antibodies in sufficient quantities to detect them. During vaccination, the immune system is trained to optimize the immune response. The formation of IgG antibodies makes you (possibly) immune to another attack from the same virus. However, it is not yet clear how long protection will last. With this test, we can demonstrate whether and to what extent IgG antibodies are produced in your body after infection with COVID-19 or after vaccination.
About the Test
The EUROIMMUN IgG Test for COVID-19 Antibodies is the latest development by EUROIMMUN for the quantitative detection of IgG antibodies against the coronavirus (SARS-CoV-2). Using a blood sample, the test can detect antibodies against the new coronavirus that causes COVID-19, which would indicate whether a person is or has already been infected or vaccinated and may have developed immunity to the virus. The high specificity of the test is critical to reliably determine whether a person has been exposed to the virus and whether they have developed antibodies.
The EUROIMMUN serological test measures the quantity of IgG antibodies in the blood. This quantitative assay uses a recombinant S1 subunit of the SARS-CoV-2 spike protein, allowing for quantitative detection of IgG antibodies. The production of IgG antibodies specifically is the focus for various vaccine developers such as BioNtech/Pfizer, Moderna, AstraZeneca en Johnson & Johnson.
It should be noted it can take 2 to 3 weeks for your body to produce the correct antibodies in sufficient quantities to detect them. The test is reliable for the detection of IgG antibodies when taken 14 days after the onset of the first symptoms of COVID-19. The test is reliable for the detection of IgG antibodies after vaccination when taken 14 days after receiving the second dose of the COVID-19 vaccine.
The test process
This test uses a dry blood spot test delivered to your home to obtain a blood sample. To collect the sample, you must prick yourself using the enclosed disposable lancets and deposit a small quantity of blood onto the paper blood spot card provided. After collecting the sample, send the materials to one of our certified partner laboratories by using the prepaid return envelope. Once the test results are available, they will be reviewed by a doctor and shared with you. All of our tests are CE certified laboratory tests and are absolutely not ‘quick tests’!
How It Works
Order Your Test
Once you have placed your order, your test kit will be delivered within days and in discreet packaging.
Activate & Collect Sample
After online activation of your test kit, you can collect your sample within a few minutes and mail it back to us in the pre-paid envelope.
View Results
A certified laboratory will review your sample and your test results will be available within a matter of days.
Reviews
Frequently Asked Questions
COVID-19 is caused by the coronavirus: SARS-CoV-2. The disease can cause respiratory problems and fever, and can be similar to a cold (with symptoms such as chills, a runny nose, sneezing and a sore throat). The disease can cause pneumonia and in severe cases can lead to respiratory problems that result in death. Other common symptoms include cough, fatigue, aches, muscle pain, dizziness, headache, diarrhoea, vomiting, and conjunctivitis. The virus was discovered in Wuhan, China in early 2020 and has since spread worldwide. The coronavirus has caused a global pandemic and is a new public health emergency.
COVID-19 spreads easily from person to person through coughing and sneezing. For example, when an infected person coughs, sneezes, or exhales, tiny droplets of the virus are deposited into the air. Other people can become infected by inhaling these droplets or by touching their eyes, nose or mouth after touching surfaces that have been in contact with these droplets.
The incubation period is the number of days between the time one becomes infected and the time one develops symptoms. The incubation period is between 2 and 14 days for SARS-CoV-2, with symptoms usually appearing after 5 to 6 days.
Most people who contract COVID-19 have mild symptoms. People with an increased risk of developing serious illness are people over 70 years old (especially frail elderly people with other medical conditions) and adults (> 18 years) with: severe chronic abnormalities and functional disorders of the airways and lungs (asthma / COPD ), chronic heart disease, diabetes mellitus (poorly controlled DM or with secondary complications), severe kidney disease, adults with reduced resistance to infections: taking medication for autoimmune diseases, after organ or stem cell transplantation, haematological conditions, patients during and within 3 months after chemotherapy and/or radiation for cancer, HIV (untreated HIV or with low CD4 count (<200 / mm3)), mild to severe liver disease and adults with morbid obesity (BMI> 40).
Most countries, including the European Union, have already started to vaccinate. Most nationwide vaccination programs have started early 2021.
We recommend this test to people 18 or older who want to know if they have been exposed to the coronavirus or want to know if they have developed sufficient antibodies to protect them against future COVID-19 infections.
- People under 18 years old
- People who are currently experiencing severe symptoms of COVID-19. In that case, we recommend that you seek immediate medical attention.
- Anyone with complaints of COVID-19 arising less than 14 days ago
- Anyone previously exposed to the virus who was vaccinated less than 14 days ago
Homed-IQ uses a lab test that will be delivered to your home. Once you have taken the test, you may send the test material to the laboratory where the blood sample will be analyzed. Your test result will then be assessed by a doctor before the result will be returned to you. All our products are CE certified laboratory tests and not ‘quick tests’.
